Table 3.
Resistant genes in ESBL-producing isolates from E. coli bloodstream isolates from 2016 to 2019.
| Genes | Number of isolates (%) | ||||
|---|---|---|---|---|---|
| 2016 | 2017 | 2018 | 2019 | Total | |
| ESBL | 8 (40.0) | 13 (65.0) | 13 (65.0) | 13 (65.0) | 47 (58.8) |
| bla CTX−M−3 | 1 (12.5) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (2.1) |
| bla CTX−M−14 | 1 (12.5) | 5 (38.5) | 6 (46.2) | 4 (30.8) | 16 (34.0) |
| bla CTX−M−15 | 3 (37.5) | 3 (23.1) | 2 (15.4) | 3 (23.1) | 11 (23.4) |
| bla CTX−M−27 | 0 (0.0) | 2 (15.4) | 0 (4.0) | 5 (38.5) | 7 (14.9) |
| bla CTX−M−55 | 0 (0.0) | 2 (15.4) | 4 (30.8) | 0 (0.0) | 6 (12.8) |
| bla CTX−M−199 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (7.7) | 1 (2.1) |